Ksaverta® 15 mg

The International Nonproprietory Name: Rivaroxaban
Indications for use:

Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrence of DVT and PE, as well as prevention of thrombosis in coronary heart disease and peripheral artery diseases, regardless of food intake.
  • Dosage and packaging
    15 mg №30
  • Scope of application
  • Form of vacation
    On prescription
  • Pharmacotherapeutic group